PAD2 dysregulation and aberrant protein citrullination feature prominently in reactive astrogliosis and myelin protein aggregation in sporadic ALS
dc.contributor.author | Yusuf, Issa O | |
dc.contributor.author | Parsi, Sepideh | |
dc.contributor.author | Ostrow, Lyle W | |
dc.contributor.author | Brown, Robert H | |
dc.contributor.author | Thompson, Paul R | |
dc.contributor.author | Xu, Zuoshang | |
dc.date.accessioned | 2024-05-24T18:34:26Z | |
dc.date.available | 2024-05-24T18:34:26Z | |
dc.date.issued | 2024-01-21 | |
dc.identifier.citation | Yusuf IO, Parsi S, Ostrow LW, Brown RH, Thompson PR, Xu Z. PAD2 dysregulation and aberrant protein citrullination feature prominently in reactive astrogliosis and myelin protein aggregation in sporadic ALS. Neurobiol Dis. 2024 Mar;192:106414. doi: 10.1016/j.nbd.2024.106414. Epub 2024 Jan 21. PMID: 38253209; PMCID: PMC11003460. | en_US |
dc.identifier.eissn | 1095-953X | |
dc.identifier.doi | 10.1016/j.nbd.2024.106414 | en_US |
dc.identifier.pmid | 38253209 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/53370 | |
dc.description.abstract | Alteration in protein citrullination (PC), a common posttranslational modification (PTM), contributes to pathogenesis in various inflammatory disorders. We previously reported that PC and protein arginine deiminase 2 (PAD2), the predominant enzyme isoform that catalyzes this PTM in the central nervous system (CNS), are altered in mouse models of amyotrophic lateral sclerosis (ALS). We now demonstrate that PAD2 expression and PC are altered in human postmortem ALS spinal cord and motor cortex compared to controls, increasing in astrocytes while trending lower in neurons. Furthermore, PC is enriched in protein aggregates that contain the myelin proteins PLP and MBP in ALS. These results confirm our findings in ALS mouse models and suggest that altered PAD2 and PC contribute to neurodegeneration in ALS. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Neurobiology of Disease | en_US |
dc.relation.url | https://doi.org/10.1016/j.nbd.2024.106414 | en_US |
dc.rights | © 2024 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by- nc-nd/4.0/). | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Deimination | en_US |
dc.subject | Myelin degeneration | en_US |
dc.subject | Neurodegeneration | en_US |
dc.subject | Neurodegenerative disease | en_US |
dc.subject | Neuroinflammation | en_US |
dc.subject | Protein aggregation | en_US |
dc.title | PAD2 dysregulation and aberrant protein citrullination feature prominently in reactive astrogliosis and myelin protein aggregation in sporadic ALS | en_US |
dc.type | Journal Article | en_US |
dc.source.journaltitle | Neurobiology of disease | |
dc.source.volume | 192 | |
dc.source.beginpage | 106414 | |
dc.source.endpage | ||
dc.source.country | United States | |
dc.source.country | United States | |
dc.source.country | United States | |
dc.identifier.journal | Neurobiology of disease | |
refterms.dateFOA | 2024-05-24T18:34:28Z | |
dc.contributor.department | Biochemistry and Molecular Biotechnology | en_US |
dc.contributor.department | Neurology | en_US |
dc.contributor.department | RNA Therapeutics Institute | en_US |
dc.contributor.department | Thompson Lab | en_US |